Details of the novel pharmacokinetic assay for measuring SAB-142.

A new single-cell brain atlas reveals how midbrain neurons develop, helping refine Parkinson’s disease models and improve cell therapy protocols.

Career Paths Available with UGC NET Qualification Achieving a passing score on the UGC NET exam unlocks a variety of career ...

Combination with bispecific T-cell engagers amplifies T-cell recruitment and cytotoxic activity against tumor cells -- Düsseldorf, Germany, November 4, 2025 – Abalos Therapeutics announced today that ...

Amazon launched a $68 million AI PhD Fellowship supporting over 100 students at nine elite universities including Johns ...

CTX-10726 demonstrated potent, simultaneous inhibition of tumor angiogenesis and PD-1-mediated immune suppression, and eliminated tumors in ...

Scientists from Duke-NUS Medical School and their collaborators have created one of the most comprehensive single cell maps ...

French and Francophone Philosophers and the Development of LGBTQIA+ Movements in the 20th Century CALL FOR PAPERS About the ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

Scientists from Duke-NUS Medical School and their collaborators have created one of the most comprehensive single cell maps of the developing human brain. The atlas captures nearly every cell type, ...

Learn how HUSKYLENS 2 simplifies AI vision with its dual-core processor, modular hardware, and compatibility with popular ...

US FDA grants 510(k) clearance to QuidelOrtho’s VITROS hs Troponin I Assay: San Diego Tuesday, November 4, 2025, 18:00 Hrs ...